IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.240
-0.040 (-3.13%)
Mar 28, 2025, 4:00 PM EDT - Market closed

IGM Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Revenue
2.682.131.07--
Upgrade
Revenue Growth (YoY)
25.77%99.25%---
Upgrade
Cost of Revenue
155.19213.79179.29127.0365.03
Upgrade
Gross Profit
-152.51-211.66-178.22-127.03-65.03
Upgrade
Selling, General & Admin
41.7149.9849.7438.318.25
Upgrade
Operating Expenses
41.7149.9849.7438.318.25
Upgrade
Operating Income
-194.22-261.64-227.96-165.32-83.28
Upgrade
Interest & Investment Income
12.7917.747.040.161.93
Upgrade
Other Non Operating Income (Expenses)
-6.88-9.16-2.890.62-
Upgrade
EBT Excluding Unusual Items
-188.32-253.05-223.82-164.54-81.36
Upgrade
Merger & Restructuring Charges
-14.36-1.83---
Upgrade
Gain (Loss) on Sale of Investments
6.889.142.71-0.62-
Upgrade
Pretax Income
-195.8-245.74-221.1-165.16-81.36
Upgrade
Income Tax Expense
-0.68---
Upgrade
Net Income
-195.8-246.42-221.1-165.16-81.36
Upgrade
Net Income to Common
-195.8-246.42-221.1-165.16-81.36
Upgrade
Shares Outstanding (Basic)
6152423331
Upgrade
Shares Outstanding (Diluted)
6152423331
Upgrade
Shares Change (YoY)
15.68%25.92%24.09%8.88%241.82%
Upgrade
EPS (Basic)
-3.24-4.71-5.32-4.93-2.65
Upgrade
EPS (Diluted)
-3.24-4.71-5.32-4.93-2.65
Upgrade
Free Cash Flow
-158.85-204.61-16.06-138.23-85.38
Upgrade
Free Cash Flow Per Share
-2.63-3.91-0.39-4.13-2.78
Upgrade
Operating Margin
-7249.61%-12283.33%-21324.23%--
Upgrade
Profit Margin
-7308.51%-11568.83%-20683.07%--
Upgrade
Free Cash Flow Margin
-5929.38%-9606.20%-1502.24%--
Upgrade
EBITDA
-185.11-253.36-221.88-160.84-82.26
Upgrade
D&A For EBITDA
9.118.286.084.481.03
Upgrade
EBIT
-194.22-261.64-227.96-165.32-83.28
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q